about
Invariant NKT cells as novel targets for immunotherapy in solid tumorsThe role of NKT cells in tumor immunitySustained expansion of NKT cells and antigen-specific T cells after injection of alpha-galactosyl-ceramide loaded mature dendritic cells in cancer patients.Effects of Invariant NKT Cells on Parasite Infections and Hygiene HypothesisSynthetic glycolipid activators of natural killer T cells as immunotherapeutic agentsDoes an NKT-cell-based immunotherapeutic approach have a future in multiple myeloma?Immunoregulation of NKT Cells in Systemic Lupus ErythematosusRecognition of Microbial Glycolipids by Natural Killer T CellsCD1d- and MR1-Restricted T Cells in SepsisCoevolution of T-cell receptors with MHC and non-MHC ligandsImaging of NKT Cell Recirculation and Tissue Migration during Antimicrobial ImmunityDiscovery of NKT cells and development of NKT cell-targeted anti-tumor immunotherapyControl of intestinal homeostasis through crosstalk between natural killer T cells and the intestinal microbiotaFine tuning a well-oiled machine: Influence of NK1.1 and NKG2D on NKT cell development and functionThe functions of type I and type II natural killer T cells in inflammatory bowel diseasesThe dynamic interdependence of amebiasis, innate immunity, and undernutrition.The significance and regulatory mechanisms of innate immune cells in the development of sepsisNKT cell networks in the regulation of tumor immunityEx vivo purification and characterization of human invariant Natural Killer T cellsThe regulatory role of invariant NKT cells in tumor immunityThe immunoregulatory role of type I and type II NKT cells in cancer and other diseasesExpression of CD11c Is Associated with Unconventional Activated T Cell Subsets with High Migratory PotentialEBV promotes human CD8 NKT cell developmentActivation of invariant NKT cells exacerbates experimental visceral leishmaniasisDifferential Recognition of CD1d-α-Galactosyl Ceramide by the Vβ8.2 and Vβ7 Semi-invariant NKT T Cell ReceptorsA Molecular Basis for the Exquisite CD1d-Restricted Antigen Specificity and Functional Responses of Natural Killer T CellsGalactose-modified iNKT cell agonists stabilized by an induced fit of CD1d prevent tumour metastasis.A semi-invariant Vα10+ T cell antigen receptor defines a population of natural killer T cells with distinct glycolipid antigen-recognition propertiesType II natural killer T cells use features of both innate-like and conventional T cells to recognize sulfatide self antigensRecognition of β-linked self glycolipids mediated by natural killer T cell antigen receptorsCutting Edge: Structural Basis for the Recognition of -Linked Glycolipid Antigens by Invariant NKT CellsHuman and Mouse Type I Natural Killer T Cell Antigen Receptors Exhibit Different Fine Specificities for CD1d-Antigen ComplexNKT TCR Recognition of CD1d- -C-GalactosylceramideThe Molecular Basis for Recognition of CD1d/α-Galactosylceramide by a Human Non-Vα24 T Cell ReceptorCrystal Structures of Bovine CD1d Reveal Altered αGalCer Presentation and a Restricted A’ Pocket Unable to Bind Long-Chain GlycolipidsV 2 natural killer T cell antigen receptor-mediated recognition of CD1d-glycolipid antigenStructural Basis for the Recognition of C20:2-αGalCer by the Invariant Natural Killer T Cell Receptor-like Antibody L363A conserved human T cell population targets mycobacterial antigens presented by CD1bRecognition of CD1d-sulfatide mediated by a type II natural killer T cell antigen receptorThe Role of Lymphocytes in Radiotherapy-Induced Adverse Late Effects in the Lung
P2860
Q21284987-C306A5C3-BD21-49BE-8803-E165444F0FCAQ24648939-FCD4065F-F576-4FE4-A3CA-90B3035CB9F1Q25255724-2630DBF4-A3AE-4434-829F-389641D5DD1FQ26738653-10DD1BD5-61AA-4A43-97E5-08CF85BB3241Q26748456-66A4BAA0-DCE8-4F7F-A67A-A08AB8901387Q26768699-E561D055-2395-471A-BB71-0C10B16C77FEQ26773074-EBBED10E-BF27-4966-8D43-C6106E600367Q26795468-71831A4A-7A43-46A1-BBC6-F6957A20C62DQ26796132-2B6169D7-2057-4A78-A778-135A8A310FB6Q26797242-2CD62584-FC06-4C37-875F-002208CD12ACQ26799999-FAED96AC-847B-43E9-A5A3-AB02B0BFD618Q26801584-28BE48C8-36D3-4041-9BB0-DAF20EBDFF15Q26825320-554ACC2D-E880-41C2-B763-EF4D3E6F2E11Q26830239-5B1D1F59-BBF9-4918-8917-92B5237FD6C0Q26865391-CC016F52-B774-4959-8E10-81FBDA5D472FQ26866034-44A148B9-476E-4E38-AF82-05D11CCC4940Q26866126-0D7FCEC4-2B70-4F8A-8161-A36AB5EA1CC7Q26866223-033C3C07-F889-4BB0-970E-7B7E6F2BF7AAQ27022218-C909DA54-BDCE-4230-9FB6-646295E8EEFDQ27023425-5CD46E99-56F9-42A3-B0E2-9D67D8956F92Q27027556-2DE63DE8-B07F-453A-97C8-2BAEC8BFE957Q27312290-1E6F1F15-ED6C-4A98-AE6A-3C19B321FA80Q27314724-A09A30FC-BAC4-490B-9C54-9E6A0D8FA0DEQ27318814-13B891FE-16DE-4EB0-97A7-C4BDE5F80F87Q27646525-9BC2030A-8546-4D30-99BB-3F4B8E6314DBQ27667168-936746DA-162D-4DBC-A5C1-0BE28EBF64D2Q27667759-1962A69E-D5AA-4B18-91D3-915589A0D7F3Q27670418-37E8F1A3-F457-44FF-9B2E-C467AB123FC5Q27670856-4AC9A4CD-C9D9-4EB5-926A-EB43B94E8EE0Q27671299-173F35ED-C722-444A-B9C8-C6E5F03D6EB8Q27671401-DF759326-1CA0-48C8-92E5-A774045F8673Q27673493-E148D15E-A7ED-4679-9D72-44D035C87173Q27674653-CE03688F-2A73-4F9C-8C09-3EBF48362318Q27674792-448AC3EF-0E8C-47F5-91BB-1F55D76529EDQ27674794-6E6B846E-BF81-40EF-AEF3-177E97EC60C1Q27675443-3C0D8CD9-8652-4361-A7A8-050BE9A1009FQ27675769-6C03FCE1-1EE8-49EE-895C-F5495709FDE3Q27678457-FCA8ED4E-0E1A-4DEA-9404-DCF26D6714A4Q27681807-743BD1E1-7A36-453F-A18E-B7A0DB3EB29AQ28070412-86F75EEC-4333-4B53-8CF9-1CDB6D90E7FE
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
NKT cells: what's in a name?
@en
NKT cells: what's in a name?
@nl
type
label
NKT cells: what's in a name?
@en
NKT cells: what's in a name?
@nl
prefLabel
NKT cells: what's in a name?
@en
NKT cells: what's in a name?
@nl
P50
P356
P1476
NKT cells: what's in a name?
@en
P2093
H Robson MacDonald
P304
P356
10.1038/NRI1309
P577
2004-03-01T00:00:00Z